Aberrant NF-κB activation and elevated expression of NF-κB target genes, in particular those encoding anti-apoptotic molecules, have been acknowledged as key factors facilitating colon cancer survival and development (Song et al., 2014; Townson et al., 2003; Zubair and Frieri, 2013). Here, NFKB1 is linked to malignant colon neoplasm.